Dai, Chia-Yen

Publishing since 2000 (Senior)

Has published 103 publications in 11 years

Number of publications published per year by Dai, Chia-Yen. (Source : PubMed)

Distribution of publications types for Dai, Chia-Yen. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Dai CY, Huang JF, Hsieh MY, Chuang WL, Yu ML. Insulin resistance, viral load and response to peginterferon and ribavirin in patients with chronic hepatitis C virus infection.  Gut  2010;59;3  
•  Huang CF, Yang JF, Dai CY, Huang JF, Hou NJ, Hsieh MY, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Chuang WL, Yu ML. Efficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis C.  J. Infect. Dis.  2010;201;5  
•  Hsieh MH, Lin WY, Dai CY, Huang JF, Huang CK, Chien HH, Wang CL, Chung WL, Wu JR, Chen ER, Ho CK, Yu ML. Intestinal parasitic infection detected by stool examination in foreign laborers in Kaohsiung.  Kaohsiung J. Med. Sci.  2010;26;3  
•  Dai CY, Ho CK, Huang JF, Hsieh MY, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Chang WY, Yu ML, Chuang WL. Hepatitis C virus viremia and low platelet count: a study in a hepatitis B & C endemic area in Taiwan.  J. Hepatol.  2010;52;2  
•  Dai CY, Chuang WL, Hsieh MY, Huang JF, Lin YY, Chu PY, Hou NJ, Lin ZY, Chen SC, Hsieh MY, Wang LY, Yu ML. Human leukocyte antigen alleles and the response to pegylated interferon/ribavirin therapy in chronic hepatitis C patients.  Antiviral Res.  2010;85;2  
•  Jeng JE, Tsai HR, Chuang LY, Tsai JF, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY, Chang JG. Independent and additive interactive effects among tumor necrosis factor-alpha polymorphisms, substance use habits, and chronic hepatitis B and hepatitis C virus infection on risk for hepatocellular carcinoma.  Medicine (Baltimore)  2009;88;6  
•  Hsieh MH, Ho CK, Hou NJ, Hsieh MY, Lin WY, Yang JF, Chiu CC, Huang JF, Chang NC, Wang CL, Dai CY, Chuang WL, Yu ML. Abnormal liver function test results are related to metabolic syndrome and BMI in Taiwanese adults without chronic hepatitis B or C.  Int J Obes (Lond)  2009;33;11  
•  Li P, Lu W, Cao WK, Yang JM, Liang SR, Dai CY, Li XM, Xu J. [The effect of Smad4 knockdown on the activated hepatic stellate cells]  Zhonghua Gan Zang Bing Za Zhi  2009;17;10  
•  Dai CY, Huang CF, Chuang WL, Huang JF, Yu ML. The substantial role of initial ribavirin dose on the response to peginterferon alpha/ribavirin therapy in patients with genotype 1b chronic hepatitis C.  Am. J. Gastroenterol.  2009;104;9  
•  Yang JF, Lin YY, Huang JF, Liu SF, Chu PY, Hsieh MY, Lin ZY, Chen SC, Wang LY, Dai CY, Chuang WL, Yu ML. Comparison of clinical application of the Abbott HBV PCR kit and the VERSANT HBV DNA 3.0 test to measure serum hepatitis B virus DNA in Taiwanese patients.  Kaohsiung J. Med. Sci.  2009;25;8  

[ See timeline ] [ See all publications ]